Sanofi

News

Dupixent claims new territory in eosinophilic oesophagitis

Sanofi and Regeneron have added another string to the bow of their immunology blockbuster Dupixent with an FDA approval in eosinophilic oesophagitis (EoE), which could help the drug reach i

News

Insulin producers face fresh lawsuit in US over pricing

Arkansas has become the latest US state to issue a legal challenge to the big three insulin producers – Eli Lilly, Sanofi and Novo Nordisk – accusing them of deceptively driving up the pric

News

AZ, Sanofi build case for one-shot RSV antibody

A pooled analysis of data for AstraZeneca and Sanofi's respiratory syncytial virus (RSV) antibody nirsevimab has concluded that the drug is almost 80% effective at preventing lower respirat

News

Sanofi ingredients spin-out EuroAPI rises on market debut

Sanofi has completed the spin-out of its pharma ingredients business EuroAPI, with shares in the new company rising more than 3% on its starting price of €12 in early trading on the Euronex

News

Google, Sanofi back UK biotech OMass' $100m second round

OMass Therapeutics has raised an impressive $100 million in a Series B financing that is said to be the largest ever for a UK biotech focusing on small-molecule drug development.

News

Sanofi revs up manufacturing with help from McLaren

French drugmaker wants the efficiency of its manufacturing operations to go up a gear, and has joined forces with Formula One racing team McLaren to make it happen.

Dupixent claims new territory in eosinophilic oesophagitis

Insulin producers face fresh lawsuit in US over pricing

AZ, Sanofi build case for one-shot RSV antibody

Sanofi ingredients spin-out EuroAPI rises on market debut

Google, Sanofi back UK biotech OMass' $100m second round

Sanofi revs up manufacturing with help from McLaren

Dexcom is first to join FDA/CMS health tech pilot

Discover a new era of healthcare panel engagement: Grounded ...

Sanofi

Editor's Picks